After the United Kingdom, the trial of the third phase of the Oxford-AstraZeneca corona vaccine is also starting in India. On Monday, the issue was confirmed.
The University of Oxford said in a statement that 18,000 volunteers worldwide are currently receiving the vaccine. The British research team also said that every case is being monitored carefully.
The human trial was temporarily suspended last week after a vaccinator fell ill in the UK.
In a separate statement, the British drugmaker AstraZeneca said the man already had encephalitis. Which, after taking the antidote, has had a negative effect. However, after the approval of the Medicines Health Regulatory Authority M-H-R-A, the trial started again in Britain.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.